http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009242368-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_924252f92d5a166d757f62937b8d26bf
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-382
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
filingDate 2008-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5596cd89d4350cf9fe9a828a2673e83d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd23ae43cd73942456397864d5183707
publicationDate 2009-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009242368-A
titleOfInvention Dorzolamide hydrochloride ophthalmic solution
abstract PROBLEM TO BE SOLVED: To provide dorzolamide hydrochloride ophthalmic solution with reduced eye irritation. SOLUTION: Dorzolamide hydrochloride (chemical name: (−)-(4S, 6S) -4-ethylamino-5,6-dihydro-6-methyl-4H-thieno [2,3-b] thiopyran-2-sulfonamide 7,7 In an ophthalmic solution containing -dioxide monohydrochloride) as an active ingredient, the present inventors have found conditions under which eye irritation is reduced. An ophthalmic solution in which dorzolamide hydrochloride is dissolved in purified water or the like has eye irritation at the time of instillation.Here, in general, when the pH of the ophthalmic solution listed as one factor of eye irritation was confirmed, Although it was 5.5 to 5.9 in the acidic region, as a result of intensive studies by the present inventors, the condition under which eye irritation is reduced when instilled with Dorzolamide hydrochloride ophthalmic solution is pH in the neutral region. In particular, it was found to be 6.5 to 8.5. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110903299-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111084758-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015029923-A1
priorityDate 2008-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08291065-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002506461-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007191414-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004359679-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426246
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918132

Total number of triples: 22.